In a recent press release, Phibro Animal Health Corporation proudly announced the release of its third annual Environmental, Social, and Governance (ESG) Report, showcasing the company’s accomplishments in 2023. Recognizing the interconnectedness between people, animals, and the planet, Phibro strives to optimize animal health and nutrition for a better future and a sustainable world.
According to Jack Bendheim, President, CEO, and Chair of Phibro Animal Health, the company’s business segments naturally align with today’s ESG and corporate responsibility mindset. The report highlights Phibro’s commitment to upholding industry standards and actively contributing to the well-being of animals, the environment, and society as a whole.
One notable recent development in Phibro’s journey towards advancing animal health is their agreement with Zoetis Inc. to acquire Zoetis’ medicated feed additive (MFA) product portfolio, along with certain water-soluble products and related assets. The transaction, valued at $350 million, is subject to customary closing adjustments and is expected to be completed in the second half of the calendar year 2024.
Phibro Animal Health’s acquisition of Zoetis’ MFA product portfolio further underscores the company’s commitment to improving animal nutrition and well-being. With this strategic move, Phibro aims to enhance its product offerings and strengthen its position as a leading provider of animal health solutions.
The release of Phibro’s ESG report and the acquisition of Zoetis’ MFA portfolio reflect the company’s dedication to being a responsible corporate entity. By actively working towards sustainable practices, Phibro continues to demonstrate its commitment to driving positive change within the animal health industry.
With their comprehensive ESG initiatives and ongoing efforts to advance animal health, nutrition, and sustainability, Phibro Animal Health Corporation remains fully committed to contributing to a better future for animals, humans, and the planet as a whole.
Comments